Tectonic Therapeutic, Inc. — Director's Dealing 2020

Mar 6, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AVROBIO, Inc. (AVRO)
CIK: 0001681087
Period of Report: 2020-03-04

Reporting Person: Volck Birgitte (President of R&D)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-03-04	Stock Option (Right to Buy)	$21.44	A	76000	Acquired	2030-03-03	Common Stock (76000)	Direct

Footnotes

F1: 25% of the shares shall vest and become exercisable on February 3, 2021, and the remaining 75% shall vest in equal monthly installments thereafter over a 3 year period.